- Home
- ACA vs PTGX Comparison
ACA vs PTGX Comparison
Compare ACA & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACA | PTGX |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | United States |
| Employees | 6250 | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.4B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | ACA | PTGX |
|---|---|---|
| Price | $111.48 | $85.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $115.00 | $90.56 |
| AVG Volume (30 Days) | 248.1K | ★ 1.1M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | ★ 0.18% | N/A |
| EPS Growth | ★ 14.96 | N/A |
| EPS | ★ 3.02 | 0.72 |
| Revenue | ★ $2,832,900,000.00 | $209,217,000.00 |
| Revenue This Year | $13.27 | N/A |
| Revenue Next Year | $6.01 | $296.47 |
| P/E Ratio | ★ $36.79 | $119.48 |
| Revenue Growth | ★ 13.96 | N/A |
| 52 Week Low | $68.11 | $33.70 |
| 52 Week High | $113.25 | $96.54 |
Technical Indicators
Market Signals| Indicator | ACA | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 66.40 | 47.49 |
| Support Level | $107.19 | $84.11 |
| Resistance Level | $111.07 | $96.54 |
| Average True Range (ATR) | 2.65 | 3.32 |
| MACD | -0.13 | -0.87 |
| Stochastic Oscillator | 81.71 | 18.55 |
Price Performance
Historical ComparisonAbout ACA Arcosa Inc.
Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.